MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$28,829K
Free Cash flow
$14,068K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales or maturitie...
Stock-based compensation expense
Deferred income tax expense
Others
Negative Cash Flow Breakdown
Selling, general and administrat...
Cost of goods sold
Purchases of investments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
200,581
204,583
269,077
642,904
Cost of goods sold
29,122
27,671
36,071
97,154
Research and development expense
24,698
25,826
24,942
78,223
Selling, general and administrative expense (excluding advertising expense)
128,341
130,558
129,093
380,619
Advertising expense
18,934
21,646
32,860
82,065
Operating income (loss)
-514
-1,118
46,111
4,843
Other income
3,629
3,515
4,208
10,535
Income tax expense
2,801
13,691
-85,771
6,046
Net (loss)
314
-11,294
136,090
9,332
Depreciation and amortization
4,597
5,110
3,822
3,677
Accretion of investment discount
237
290
377
394
Stock-based compensation expense
31,226
30,689
28,012
29,467
Deferred income taxes (benefit)
-
-
-88,749
-
Deferred income tax expense
10,152
1,009
-
-
Provision for estimated credit losses
-
186
-18
-132
Impairment charge
0
-
0
0
Other non-cash expenses
193
548
543
535
Accounts receivable
-1,927
-14,285
11,634
-29,722
Inventories
4,217
20,942
3,516
20,144
Prepaid expenses and other current assets
2,805
1,262
-3,763
1,473
Accounts payable
-13,831
7,132
-22,098
6,535
Accrued expenses and other liabilities
-3,905
-12,322
6,631
10,801
Net cash provided by (used in) operating activities
23,228
12,849
52,469
68,526
Capital expenditures
9,160
9,726
10,656
10,439
Purchases of investments
24,934
57,312
62,943
68,655
Proceeds from sales or maturities of investments
37,642
55,789
61,681
75,049
Purchases of strategic investments
-
-
0
7,600
Net cash (used in) provided by investing activities
3,548
-11,249
-11,918
-11,645
Proceeds from the exercise of stock options
403
109
633
347
Accelerated share repurchase of common stock
-
-
0
-
Share repurchase of common stock
0
0
50,011
49,999
Payment of taxes on net share settlement of equity awards
685
7,591
694
1,426
Proceeds from issuance of common stock from employee stock purchase plan
2,193
-
1,764
0
Net cash (used in) financing activities
1,911
-7,482
-48,308
-51,078
Effect of exchange rate on cash
142
1
-275
115
Increase (decrease) in cash and cash equivalents
28,829
-5,881
-8,032
5,918
Cash and cash equivalents at beginning of period
98,932
104,813
112,845
150,150
Cash and cash equivalents at end of period
127,761
98,932
104,813
112,845
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Other income
$3,629K
Stock-based compensation
expense
$31,226K
(-57.10%↓ Y/Y)
Proceeds from sales or
maturities of investments
$37,642K
(-78.32%↓ Y/Y)
Proceeds from issuance of
common stock from...
$2,193K
(-32.63%↓ Y/Y)
Deferred income tax
expense
$10,152K
Depreciation and
amortization
$4,597K
(-28.82%↓ Y/Y)
Accounts receivable
-$1,927K
(-104.35%↓ Y/Y)
Net (loss)
$314K
Other non-cash
expenses
$193K
(-81.32%↓ Y/Y)
Proceeds from the
exercise of stock options
$403K
(-95.32%↓ Y/Y)
Canceled cashflow
$3,315K
Revenue
$200,581K
Net cash provided by
(used in) operating...
$23,228K
(677.95%↑ Y/Y)
Net cash (used in)
provided by investing...
$3,548K
(-92.12%↓ Y/Y)
Net cash (used in)
financing activities
$1,911K
(102.27%↑ Y/Y)
Effect of exchange rate
on cash
$142K
(194.67%↑ Y/Y)
Canceled cashflow
$24,995K
Canceled cashflow
$34,094K
Canceled cashflow
$685K
Income tax expense
$2,801K
Operating income (loss)
-$514K
Canceled cashflow
$200,581K
Increase (decrease) in
cash and cash...
$28,829K
(166.70%↑ Y/Y)
Accounts payable
-$13,831K
(-217.05%↓ Y/Y)
Inventories
$4,217K
(-89.84%↓ Y/Y)
Accrued expenses and
other liabilities
-$3,905K
(65.47%↑ Y/Y)
Prepaid expenses and
other current assets
$2,805K
(338.97%↑ Y/Y)
Accretion of investment
discount
$237K
(-88.81%↓ Y/Y)
Purchases of investments
$24,934K
(-77.07%↓ Y/Y)
Capital expenditures
$9,160K
(-47.37%↓ Y/Y)
Payment of taxes on net
share settlement of...
$685K
(-96.73%↓ Y/Y)
Selling, general and
administrative expense...
$128,341K
Cost of goods sold
$29,122K
Research and development
expense
$24,698K
Advertising expense
$18,934K
Buy us a coffee
Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. (INSP)